Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3066% above fair value
$8.30−0.26 (-3.04%)
Close on Nov 13, 2026Market cap $180.76MP/E –Yield –
Alpha Cognition operating margin
Operating margin is operating income as a percentage of revenue.
Alpha Cognition's operating margin for the twelve months ending Sep 30, 2026 was -146.9%. For fiscal 2025 it was -221.7%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -221.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -82.7% | +37.7 |
| Q2 FY2026 | Jun 30, 2026 | -127.3% | +382.3 |
| Q1 FY2026 | Mar 31, 2026 | -229.1% | −112.8 |
| Q4 FY2025 | Dec 31, 2025 | -264.5% | – |
| Q3 FY2025 | Sep 30, 2025 | -120.4% | – |
| Q2 FY2025 | Jun 30, 2025 | -509.6% | – |
| Q1 FY2025 | Mar 31, 2025 | -116.3% | – |
See a number that looks wrong?